The Rivals With No Name in Greater ChinaThin moat

Procter & Gamble (PG) — moat facet

In Greater China P&G's baby care sales rose about 20% while SK-II and oral care lost to competitors the company never names.

In Greater China P&G's rivals are not the global peers but competitors its filings never name. The 10-K attributes volume losses in Greater China skin care and oral care to competitive activity1. Skin care share fell 0.6 points in fiscal 2026, with SK-II volume declining in Greater China2, and oral care organic sales there fell by mid-teens3.

P&G net sales outside the United States ($bn)43.5FY202442.7FY202545.3FY2026P&G Form 10-K FY2026; Greater China is one of five markets that together make about 21% of sales
Winning nappies, losing skin care and brushes.

Greater China matters to P&G's mix. With the UK, Canada, Japan and Germany it is among P&G's largest international markets, which together make up about 21% of net sales4.

The same market also produced P&G's best category result. Greater China baby care organic sales rose about 20% in fiscal 20265. So the competition is not against P&G as a company; it is against specific brands in specific categories, where local rivals have been faster to meet shoppers' preferences.

This is a different kind of competitor from any on the other pages. It is not a peer P&G can benchmark, a customer that also competes, or a partner. It is an unnamed field in a market where P&G's brands arrived as imports and now face domestic champions. The oral care decline has its own page under the moat; here the point is that the contest is invisible in P&G's disclosures except through its results.

The skin care losses continued into the final quarter, with share down 0.5 points6. Skin care is only 4% of P&G's net sales7, but it carries the premium SK-II brand, so share lost there costs more margin than the same share lost in a mass category.

China is now a market where P&G is gaining in one category and losing in two. The number to follow is Greater China baby care growth, about 20% in fiscal 20268; if that fades while skin and oral care keep falling, P&G will be losing China category by category to rivals it cannot even name.

Moat trajectory: Narrowing

Greater China skin care and oral care losing to competitive activity; baby care +20%.

The number that tests this moat
Reported
Greater China baby care organic sales growth, FY2026
About +20%

The category where P&G is winning in China; fading growth with skin and oral care still falling would mean losing the market piece by piece.

Source: P&G Form 10-K, FY2026 ↗
References
  1. ReportedThe 10-K attributes volume losses in Greater China skin care and oral care to competitive activity.
    Procter & Gamble Form 10-K for fiscal 2026 (year ended 30 June 2026) - Item 7 MD&A: market shares and competitive activity by category. — FY2026 · publ. 4 August 2026 · source ↗
  2. ReportedSkin care share fell 0.6 points in fiscal 2026, with SK-II volume declining in Greater China, and oral care organic sales there fell by mid-teens.
    Procter & Gamble Form 10-K for fiscal 2026 (year ended 30 June 2026) - Item 7 MD&A: market shares and competitive activity by category. — FY2026 · publ. 4 August 2026 · source ↗
  3. ReportedSkin care share fell 0.6 points in fiscal 2026, with SK-II volume declining in Greater China, and oral care organic sales there fell by mid-teens.
    Procter & Gamble Form 10-K for fiscal 2026 (year ended 30 June 2026) - Item 7 MD&A: market shares and competitive activity by category. — FY2026 · publ. 4 August 2026 · source ↗
  4. ReportedWith the UK, Canada, Japan and Germany it is among P&G's largest international markets, which together make up about 21% of net sales.
    Procter & Gamble Form 10-K for fiscal 2026 (year ended 30 June 2026) - Item 1 business and Item 2 properties: employees, manufacturing sites, customers, channels, competition and strategy. — FY2026 · publ. 4 August 2026 · source ↗
  5. ReportedGreater China baby care organic sales rose about 20% in fiscal 2026.
    Procter & Gamble Form 10-K for fiscal 2026 (year ended 30 June 2026) - Item 7 MD&A: net sales drivers, organic sales and gross margin bridge. — FY2026 · publ. 4 August 2026 · source ↗
  6. ReportedThe skin care losses continued into the final quarter, with share down 0.5 points.
    Procter & Gamble fourth-quarter fiscal 2026 earnings slides, Form 8-K exhibit 99.1 - organic sales and core EPS history, share results and fiscal 2027 guidance assumptions. — Q4 FY2026 · publ. 29 July 2026 · source ↗
  7. ReportedSkin care is only 4% of P&G's net sales, but it carries the premium SK-II brand, so share lost there costs more margin than the same share lost in a mass category.
    Procter & Gamble Form 10-K for fiscal 2026 (year ended 30 June 2026) - Item 7 MD&A and segment note: segment contents, operating segments and shares of net sales and net earnings. — FY2026 · publ. 4 August 2026 · source ↗
  8. ReportedThe number to follow is Greater China baby care growth, about 20% in fiscal 2026; if that fades while skin and oral care keep falling, P&G will be losing China category by category to rivals it cannot even name.
    Procter & Gamble Form 10-K for fiscal 2026 (year ended 30 June 2026) - Note 2 segment information: net sales, earnings before tax, net earnings, margins, capital spending and depreciation by segment. — FY2026 · publ. 4 August 2026 · source ↗
Sources
Generated September 26, 2026